Specific characterization of non-steroidal selective androgen peceptor modulators using supercritical fluid chromatography coupled to ion-mobility mass spectrometry: application to the detection of enobosarm in bovine urine

Drug Testing and Analysis

Volumn 9, Issue 2, 2017, Pages 179-187

  Beucher, Laure ^a   Dervilly Pinel, Gaud ^a   Cesbron, Nora ^a   Penot, Mylène ^a   Gicquiau, Audrey ^a   Monteau, Fabrice ^a   Le Bizec, Bruno ^a  

^a LUNAM UNIVERSITÉ   (France)

Author keywords

anabolic practices; bovine; Q TWIM TOF MS; SARMs; supercritical fluid chromatography; trace concentrations; urine

Indexed keywords

AGRICULTURE; BODY FLUIDS; COPYRIGHTS; EFFLUENT TREATMENT; ION CHROMATOGRAPHY; MAMMALS; MASS SPECTROMETRY; SUPERCRITICAL FLUIDS;

ANABOLIC PRACTICE; BOVINE; BOVINE URINE; ION MOBILITY-MASS SPECTROMETRY; Q-TWIM-TOF MS; SARM; SUPER CRITICAL FLUID CHROMATOGRAPHY; SUPERCRITICAL FLUID CHROMATOGRAPHY; TRACE CONCENTRATIONS; URINE;

GAS CHROMATOGRAPHY;

ANDARINE; BICALUTAMIDE; ENOBOSARM; HYDROXYFLUTAMIDE; NON STEROIDAL SELECTIVE ANDROGEN RECEPTOR MODULATOR; SELECTIVE ANDROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG; ANABOLIC AGENT; ANDROGEN; ANILIDE;

ANIMAL EXPERIMENT; ARTICLE; BOVINE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; DRUG URINE LEVEL; ION MOBILITY SPECTROMETRY; LIMIT OF DETECTION; MALE; MEASUREMENT REPEATABILITY; NONHUMAN; SUPERCRITICAL FLUID CHROMATOGRAPHY; ANIMAL; DOPING; EVALUATION STUDY; MASS SPECTROMETRY; PROCEDURES; SUBSTANCE ABUSE; URINE;

ANABOLIC AGENTS; ANDROGENS; ANILIDES; ANIMALS; CATTLE; CHROMATOGRAPHY, SUPERCRITICAL FLUID; DOPING IN SPORTS; LIMIT OF DETECTION; MALE; MASS SPECTROMETRY; SUBSTANCE ABUSE DETECTION;

EID: 84961282301     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1951     Document Type: Article

References (32)

1. J. T. Dalton, A. Mukherjee, Z. Zhu, L. Kirkovsky, D. D. Miller. Discovery of nonsteroidal androgens. Biochem. Biophys. Res. Commun. 1998, 244, 1.
2. J. P. Edwards, S. J. West, C. L. F. Pooley, K. B. Marschke, L. J. Farmer, T. K. Jones. New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g]quinolinone. Bioorg. Med. Chem. Lett. 1998, 8, 745.
3. C. A. Marhefka, W. Gao, K. Chung, J. Kim, Y. He, D. Yin, C. Bohl, J. T. Dalton, D. D. Miller. Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators. J. Med. Chem. 2004, 47, 993.
4. J. Dalton, K. Barnette, C. Bohl, M. Hancock, D. Rodriguez, S. Dodson, R. Morton, M. Steiner. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J. Cachex. Sarcopenia Muscle. 2011, 2, 153.
5. J. Chen, J. Kim, J. T. Dalton. Discovery and therapeutic promise of selective androgen receptor modulators. Mol. Interventions. 2005, 5, 173.
6. S. Bhasin, O. M. Calof, T. W. Storer, M. L. Lee, N. A. Mazer, R. Jasuja, V. M. Montori, W. Gao, J. T. Dalton. Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat. Clin. Pract. End Met. 2006, 2, 146.
7. S. Bhasin, R. Jasuja. Selective Androgen receptor modulators (SARMs) as function promoting therapies. Curr. Opin. Clin. Nutr. Metab. Care. 2009, 12, 232.
8. E. Grata, L. Perrenoud, M. Saugy, N. Baume. SARM-S4 and metabolites detection in sports drug testing: A case report. Forensic Sci.Int. 2011, 213, 104.
9. B. Starcevic, B. D. Ahrens, A. W. Butch. Detection of the selective androgen receptor modulator S-4 (Andarine) in a doping control sample. Drug Test. Anal. 2013, 5, 377.
10. World Anti-Doping Agency. Website. Available at: http://list.wada-ama.org/ 2015. (Accessed on April 2015)
11. D. L. Trump, J. A. Waldstreicher, G. Kolvenbag, P. S. Wissel, B. L. Neubauer. Androgen antagonists: potential role in prostate cancer prevention. Urology. 2001, 57, 64.
12. F. Neumann, M. Töpert. Pharmacology of antiandrogens. J. Steroid Biochem. 1986, 25, 885.
13. M. Thevis, M. Kamber, W. Schänzer. Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. Rapid Comm. Mass Spectrom. 2006, 20, 870.
14. M. Thevis, W. Schänzer. Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls. J. Pharm. Biomed. Anal. 2014, 101, 66.
15. E. de Rijke, M. L. Essers, J. C. Rijk, M. Thevis, T. F. Bovee, L. A. van Ginkel, S. S. Sterk. Selective androgen receptor modulators: in vitro and in vivo metabolism and analysis. Food Add. Contam. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment. 2013, 30, 1517.
16. L. T. Taylor. Supercritical fluid chromatography for the 21st century. J. Supercrit. Fluids. 2009, 47, 566.
17. M. Doué, G. Dervilly-Pinel, K. Pouponneau, F. Monteau, B. Le Bizec. Analysis of glucuronide and sulfate steroids in urine by ultra-high-performance supercritical-fluid chromatography hyphenated tandem mass spectrometry. Anal. Bioanal. Chem. 2015, 1.
18. G. Guiochon, A. Tarafder. Fundamental challenges and opportunities for preparative supercritical fluid chromatography. J. Chromatog. A. 2011, 1218, 1037.
19. J. Zheng, J. D. Pinkston, P. H. Zoutendam, L. T. Taylor. Feasibility of supercritical fluid chromatography/mass spectrometry of polypeptides with up to 40-mers. Anal. Chem. 2006, 78, 1535.
20. B. Bolaños, M. Greig, M. Ventura, W. Farrell, C. M. Aurigemma, H. Li, T. L. Quenzer, K. Tivel, J. M. Bylund, P. Tran. SFC/MS in drug discovery at pfizer, la jolla. Int. J. Mass spectrom. 2004, 238, 85.
21. A. Grand-Guillaume Perrenoud, J.-L. Veuthey, D. Guillarme. Comparison of ultra-high performance supercritical fluid chromatography and ultra-high performance liquid chromatography for the analysis of pharmaceutical compounds. J. Chromatogr. A. 2012, 1266, 158.
22. K. Giles, J. P. Williams, I. Campuzano. Enhancements in travelling wave ion mobility resolution. Rapid Commun. Mass Spectrom. 2011, 25, 1559.
23. S. D. Pringle, K. Giles, J. L. Wildgoose, J. P. Williams, S. E. Slade, K. Thalassinos, R. H. Bateman, M. T. Bowers, J. H. Scrivens. An investigation of the mobility separation of some peptide and protein ions using a new hybrid quadrupole/travelling wave IMS/oa-ToF instrument. Int. J. Mass spectrom. 2007, 261, 1.
24. L. Ahonen, M. Fasciotti, G. B. Gennas, T. Kotiaho, R. J. Daroda, M. Eberlin, R. Kostiainen. Separation of steroid isomers by ion mobility mass spectrometry. J. Chromatog. A. 2013, 1310, 133.
25. C. Xie, D. Zhong, K. Yu, X. Chen. Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-OF MS. Bioanal. 2012, 4, 937.
26. S. Wickramasekara, F. Zandkarimi, J. Morré, J. Kirkwood, L. Legette, Y. Jiang, A. Gombart, J. Stevens, C. Maier. Electrospray quadrupole travelling wave ion mobility time-of-flight mass spectrometry for the detection of plasma metabolome changes caused by xanthohumol in obese zucker (fa/fa) rats. Metabolites. 2013, 3, 701.
27. G. Paglia, J. P. Williams, L. Menikarachchi, J. W. Thompson, R. Tyldesley-Worster, S. Halldorsson, O. Rolfsson, A. Moseley, D. Grant, J. Langridge, B. O. Palsson, G. Astarita. Ion mobility derived collision cross sections to support metabolomics applications. Anal. Chem. 2014, 86, 3985.
28. L. Beucher, G. Dervilly-Pinel, S. Prévost, F. Monteau, B. Le Bizec. Determination of a large set of β-adrenergic agonists in animal matrices based on ion mobility and mass separations. Anal. Chem. 2015, 87, 9234.
29. M. F. Bush, Z. Hall, K. Giles, J. Hoyes, C. V. Robinson, B. T. Ruotolo. Collision cross sections of proteins and their complexes: a calibration framework and database for gas-phase structural biology. Anal. Chem. 2010, 82, 9557.
30. M. F. Bush, I. D. Campuzano, C. V. Robinson. Ion mobility mass spectrometry of peptide ions: effects of drift gas and calibration strategies. Anal. Chem. 2012, 84, 7124.
31. M. Thevis, W. Schänzer. Mass spectrometry of selective androgen receptor modulators. J. Mass Spectrom. 2008, 43, 865.
32. M. Thevis, A. Thomas, G. Fusshöller, S. Beuck, H. Geyer, W. Schänzer. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes. Rapid Comm. Mass Spectrom. 2010, 24, 2245.